IQ-AI Limited Welcomes Brain Tumor Expert to Board

IQ-AI Limited (GB:IQAI) has released an update.

IQ-AI Limited has appointed Dr. Al Musella, a prominent figure in brain tumor research, as a Non-Executive Director. Dr. Musella’s extensive experience and influential network are expected to enhance IQ-AI’s ongoing projects in oral gallium maltolate development and its core imaging business. Meanwhile, Vinod Kaushal has resigned from his position as a non-executive director.

For further insights into GB:IQAI stock, check out TipRanks’ Stock Analysis page.